EVONETIX
evonetix is a new spin-out company that is currently incubating in the centre of the world-renowned Cambridge cluster of high-tech and life science organisations. We are seeking to develop and commercialise a new approach to the synthesis of DNA to facilitate the fast-emerging and exciting field of synthetic biology. By employing novel techniques we are able to advance DNA synthesis to levels never before seen. Our engineering team has decades of experience developing high integrity automated systems. Our high calibre team brings together expertise from across the scientific and engineering disciplines.
EVONETIX
Industry:
Biopharma Biotechnology Life Science
Founded:
2015-01-01
Address:
Little Chesterford, Essex, United Kingdom
Country:
United Kingdom
Website Url:
http://www.evonetix.com
Total Employee:
11+
Status:
Active
Total Funding:
44.01 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Echo
Echo is a provider of an automated microscope intended for biological research and pathologies.
EnteroBiotix
EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections.
PhagoMed
PhagoMed is a developer of a biotech platform designed to develop drugs and therapies.
Principia Biopharma
Principia Biopharma is dedicated to bringing oral therapies to patients with significant unmet medical needs in immunology & oncology.
Current Advisors List
Board_member
2022-02-01
Current Employees Featured
Joseph Brennan Chief Scientific Officer @ evonetix
Chief Scientific Officer
Matthew Hayes CTO @ evonetix
CTO
2015-12-01
Ray Edgson Director @ evonetix
Director
2015-08-01
Colin McCracken Chief Executive Officer @ evonetix
Chief Executive Officer
2022-06-01
Yuyin Qi Senior Scientist @ evonetix
Senior Scientist
2021-10-01
Founder
Investors List
Providence Investment Company Limited
Providence Investment Company Limited investment in Series B - evonetix
Foresite Capital
Foresite Capital investment in Series B - evonetix
Cambridge Consultants
Cambridge Consultants investment in Series B - evonetix
DCVC
DCVC investment in Series B - evonetix
Molten Ventures
Molten Ventures investment in Series B - evonetix
Civilization Ventures
Civilization Ventures investment in Series B - evonetix
Rising Tide
Rising Tide investment in Series B - evonetix
Morningside Group
Morningside Group investment in Series B - evonetix
Innovate UK
Innovate UK investment in Grant - evonetix
Cambridge Consultants
Cambridge Consultants investment in Series A - evonetix
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-13 | Evonetix Appoints Colin McCracken as Chief Executive Officer |
Official Site Inspections
http://www.evonetix.com Semrush global rank: 2.74 M Semrush visits lastest month: 5.94 K
- Host name: kisscab2.miniserver.com
- IP address: 89.200.137.201
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "evonetix"
About us - Evonetix
Evonetix was founded in 2015 with the goal of applying the scalability of silicon chip manufacture to benchtop DNA synthesis. Since the founding team developed the first DNA synthesis chip, …See details»
evonetix - Crunchbase Company Profile & Funding
Evonetix is a new spin-out company that is currently incubating in the centre of the world-renowned Cambridge cluster of high-tech and life science …See details»
Evonetix Profile | The Scientist
Evonetix raises $30 million USD (£23 million GBP) Evonetix | | 3 min read. Series B investment led by west-coast investor Foresite Capital, with all existing investors participating in the round. …See details»
Evonetix 2025 Company Profile: Valuation, Funding
Evonetix General Information Description. Operator of a biotechnology company intended to synthesize DNA at higher accuracy and scale. The company's …See details»
Evonetix | Lab Manager
Oct 2, 2023 Evonetix Evonetix is a pioneer of groundbreaking gene synthesis technology. Our benchtop platform will provide the ability to synthesize gene-length DNA at unprecedented …See details»
evonetix - Funding, Financials, Valuation & Investors - Crunchbase
Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale. ... Log In. Log In. Experience the new Crunchbase, powered by AI . …See details»
Evonetix appoints Andrew Diston as Chief Executive Officer
Mar 13, 2024 Appointment will drive the development Evonetix’s semiconductor-based gene synthesis platform. Cambridge, UK, 13 March 2024 – EVONETIX LTD (‘Evonetix’), the …See details»
Evonetix Company Profile - Office Locations, Competitors ... - Craft
Evonetix has 5 employees at their 1 location and $44.02 m in total funding,. See insights on Evonetix including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
evonetix - The Org
Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.See details»
Evonetix - VentureRadar
"Evonetix has developed a unique silicon chip that allows large-scale synthesis to occur in parallel. Rather than creating different oligos in physically separated wells, Evonetix uses …See details»
Evonetix - Products, Competitors, Financials, Employees, …
Evonetix specializes in gene synthesis technology within the biotechnology sector. The company is developing a desktop DNA synthesis platform that enables the synthesis of gene-length …See details»
Evonetix - Overview, News & Similar companies | ZoomInfo.com
Evonetix Closes $24 Million USD (£20 Million) Financing CAMBRIDGE, England--(BUSINESS WIRE)--EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor …See details»
Evonetix - Company Profile - Tracxn
Feb 14, 2025 Evonetix - Developer of synthetic biology platform. Raised a total funding of $66.7M over 4 rounds from 14 investors. Valued at $630M. Founded by Joseph Brennan, …See details»
Evonetix - Home
At evonetix, we are an emerging Global Pharmaceutical Research, Manufacturing and Marketing Company established in 2015 by a strong and experienced team of professionals having …See details»
People, Leadership Team & Board - evonetix
Our work is made possible by an exceptional, multidisciplinary team that brings together deep expertise in Chemistry, Biology, Physics, Electronics, Software, Cloud Development, …See details»
evonetix - Leadership Team - The Org
The Leadership Team at Evonetix strategizes and oversees the company's direction, ensuring the alignment of financial, technological, and product development goals. They drive innovation, …See details»
Evonetix Company Information - Funding, Investors, and More
Evonetix Series A round, January 30, 2018: $12.3m; 2023. evonetix February 2023 Series B Funding Round $24m. 2020. Evonetix Series B round, March 2020 $30m. 2018. Evonetix …See details»
EVONETIX: GENE SYNTHESIS ON A CHIP FOR LIFESAVING …
Evonetix is progressing with ADI’s platform sensor structures, building the interface and control of the biological processes on silicon devices to establish DNA processing in miniaturized form. …See details»
New branding to align with our vision for gene-length DNA
Sep 26, 2023 This is an exciting step for Evonetix. Our groundbreaking semiconductor technology reimagines gene synthesis, putting control directly into the hands of end-users and …See details»